Ambroxol: Mucolytic and Secretolytic Agent
Ambroxol (Lasolvan, Mucosolvan, Mucobrox) is a mucolytic and secretolytic agent widely used for respiratory conditions with excessive or viscous mucus. It is the pharmacologically active metabolite of bromhexine and is one of the most prescribed respiratory drugs globally.
Ambroxol also has local anaesthetic properties and anti-inflammatory effects, making it useful not only for chronic bronchitis and COPD but also for sore throat (lozenges). Available as syrup, tablets, effervescent tablets, inhalation solution, and throat lozenges.
Mechanism of Action
Ambroxol stimulates surfactant production by type II alveolar cells, reducing mucus viscosity. It also activates serous gland secretion, enhances mucociliary clearance, and has anti-inflammatory effects by inhibiting cytokine release and reducing free radical production. Its local anaesthetic effect is via sodium channel blockade.
Indications & Use
Acute and chronic bronchopulmonary diseases with impaired bronchial secretion: bronchitis, COPD, asthma, bronchiectasis. Throat lozenges for sore throat and pharyngitis. Also used to promote lung maturity in preterm infants (off-label).
Dosage
Adults: 30 mg three times daily (or 75 mg sustained-release once daily). Children (6–12 years): 15 mg two to three times daily; under 6 years: 7.5 mg two to three times daily. Adequate fluid intake is essential to enhance mucolytic effect.
Side Effects
Generally very well tolerated. Occasional: nausea, diarrhoea, oral numbness (lozenges), taste disturbance. Rare: hypersensitivity reactions, Stevens-Johnson syndrome (post-marketing). No significant drug accumulation.
Drug Interactions
Ambroxol has very few clinically relevant interactions. Combination with antibiotics (amoxicillin, erythromycin, cefuroxime) enhances antibiotic penetration into lung tissue — a therapeutically useful effect. Do not combine with cough suppressants (DXM, codeine) — the effects are antagonistic.
Contraindications
Hypersensitivity to ambroxol or bromhexine. Caution in first trimester of pregnancy, severe renal impairment, and rare conditions causing accumulation. Do not use with antitussive agents simultaneously.
Frequently Asked Questions
Should I take ambroxol with water?
Yes — adequate hydration (1.5–2 L water/day) significantly enhances the mucolytic effect by thinning mucus. Ambroxol works best when the airways stay hydrated.
Can I use ambroxol and a cough suppressant together?
No — ambroxol loosens mucus to clear it via coughing, while cough suppressants (dextromethorphan, codeine) block the cough mechanism. Combining them leads to mucus accumulation.
Is ambroxol safe during breastfeeding?
Ambroxol is excreted in breast milk. While generally considered low risk, manufacturers recommend avoiding use during breastfeeding as a precaution. Consult your doctor or pharmacist.
References
- EMA assessment of ambroxol
- Global Initiative for Chronic Obstructive Lung Disease (GOLD)
- PDPI mucolytic guidelines
Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice.